181 related articles for article (PubMed ID: 26864819)
1. Activation of MEK1/2-ERK1/2 signaling during NNK-induced lung carcinogenesis in female A/J mice.
Yamakawa K; Yokohira M; Nakano Y; Kishi S; Kanie S; Imaida K
Cancer Med; 2016 May; 5(5):903-13. PubMed ID: 26864819
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of adenoma progression to adenocarcinoma in a 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung tumorigenesis model in A/J mice by tea polyphenols and caffeine.
Lu G; Liao J; Yang G; Reuhl KR; Hao X; Yang CS
Cancer Res; 2006 Dec; 66(23):11494-501. PubMed ID: 17145898
[TBL] [Abstract][Full Text] [Related]
3. Ki-ras and the characteristics of mouse lung tumors.
Ramakrishna G; Bialkowska A; Perella C; Birely L; Fornwald LW; Diwan BA; Shiao YH; Anderson LM
Mol Carcinog; 2000 Jul; 28(3):156-67. PubMed ID: 10942532
[TBL] [Abstract][Full Text] [Related]
4. NNK activates ERK1/2 and CREB/ATF-1 via beta-1-AR and EGFR signaling in human lung adenocarcinoma and small airway epithelial cells.
Laag E; Majidi M; Cekanova M; Masi T; Takahashi T; Schuller HM
Int J Cancer; 2006 Oct; 119(7):1547-52. PubMed ID: 16671086
[TBL] [Abstract][Full Text] [Related]
5. Mutations in BRAF and KRAS converge on activation of the mitogen-activated protein kinase pathway in lung cancer mouse models.
Ji H; Wang Z; Perera SA; Li D; Liang MC; Zaghlul S; McNamara K; Chen L; Albert M; Sun Y; Al-Hashem R; Chirieac LR; Padera R; Bronson RT; Thomas RK; Garraway LA; Jänne PA; Johnson BE; Chin L; Wong KK
Cancer Res; 2007 May; 67(10):4933-9. PubMed ID: 17510423
[TBL] [Abstract][Full Text] [Related]
6. Mouse tissues that undergo neoplastic progression after K-Ras activation are distinguished by nuclear translocation of phospho-Erk1/2 and robust tumor suppressor responses.
Parikh N; Shuck RL; Nguyen TA; Herron A; Donehower LA
Mol Cancer Res; 2012 Jun; 10(6):845-55. PubMed ID: 22532587
[TBL] [Abstract][Full Text] [Related]
7. Effects of K-ras gene mutations in the development of lung lesions induced by 4-(N-methyl-n-nitrosamino)-1-(3-pyridyl)-1-butanone in A/J mice.
Kawano R; Takeshima Y; Inai K
Jpn J Cancer Res; 1996 Jan; 87(1):44-50. PubMed ID: 8609047
[TBL] [Abstract][Full Text] [Related]
8. Oncogene KRAS activates fatty acid synthase, resulting in specific ERK and lipid signatures associated with lung adenocarcinoma.
Gouw AM; Eberlin LS; Margulis K; Sullivan DK; Toal GG; Tong L; Zare RN; Felsher DW
Proc Natl Acad Sci U S A; 2017 Apr; 114(17):4300-4305. PubMed ID: 28400509
[TBL] [Abstract][Full Text] [Related]
9. Role of the alveolar type II cell in the development and progression of pulmonary tumors induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in the A/J mouse.
Belinsky SA; Devereux TR; Foley JF; Maronpot RR; Anderson MW
Cancer Res; 1992 Jun; 52(11):3164-73. PubMed ID: 1591728
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of chemopreventive effects of 8-methoxypsoralen against 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced mouse lung adenomas.
Miyazaki M; Yamazaki H; Takeuchi H; Saoo K; Yokohira M; Masumura K; Nohmi T; Funae Y; Imaida K; Kamataki T
Carcinogenesis; 2005 Nov; 26(11):1947-55. PubMed ID: 15958517
[TBL] [Abstract][Full Text] [Related]
11. Development of Kras mutant lung adenocarcinoma in mice with knockout of the airway lineage-specific gene Gprc5a.
Fujimoto J; Nunomura-Nakamura S; Liu Y; Lang W; McDowell T; Jakubek Y; Ezzeddine D; Kapere Ochieng J; Petersen J; Davies G; Fukuoka J; Wistuba II; Ehli E; Fowler J; Scheet P; Kadara H
Int J Cancer; 2017 Oct; 141(8):1589-1599. PubMed ID: 28653505
[TBL] [Abstract][Full Text] [Related]
12. Nongenomic beta estrogen receptors enhance beta1 adrenergic signaling induced by the nicotine-derived carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in human small airway epithelial cells.
Majidi M; Al-Wadei HA; Takahashi T; Schuller HM
Cancer Res; 2007 Jul; 67(14):6863-71. PubMed ID: 17638897
[TBL] [Abstract][Full Text] [Related]
13. Molecular pathogenesis of transplacentally induced mouse lung tumors.
Miller MS; Leone-Kabler S; Rollins LA; Wessner LL; Fan M; Schaeffer DO; McEntee MF; O'Sullivan MG
Exp Lung Res; 1998; 24(4):557-77. PubMed ID: 9659583
[TBL] [Abstract][Full Text] [Related]
14. Gender-dependent effects of gonadectomy on lung carcinogenesis by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in female and male A/J mice.
Ninomiya F; Yokohira M; Kishi S; Nakano Y; Yamakawa K; Inoue T; Kuno T; Imaida K
Oncol Rep; 2013 Dec; 30(6):2632-8. PubMed ID: 24085151
[TBL] [Abstract][Full Text] [Related]
15. Activation status of receptor tyrosine kinase downstream pathways in primary lung adenocarcinoma with reference of KRAS and EGFR mutations.
Hiramatsu M; Ninomiya H; Inamura K; Nomura K; Takeuchi K; Satoh Y; Okumura S; Nakagawa K; Yamori T; Matsuura M; Morikawa T; Ishikawa Y
Lung Cancer; 2010 Oct; 70(1):94-102. PubMed ID: 20117855
[TBL] [Abstract][Full Text] [Related]
16. Ki-ras mutation and cell proliferation of lung lesions induced by 1-nitropyrene in A/J mice.
Bai F; Nakanishi Y; Takayama K; Pei XH; Tokiwa H; Hara N
Mol Carcinog; 1998 Aug; 22(4):258-64. PubMed ID: 9726818
[TBL] [Abstract][Full Text] [Related]
17. Activation of ERK1/2 occurs independently of KRAS or BRAF status in endometrial cancer and is associated with favorable prognosis.
Mizumoto Y; Kyo S; Mori N; Sakaguchi J; Ohno S; Maida Y; Hashimoto M; Takakura M; Inoue M
Cancer Sci; 2007 May; 98(5):652-8. PubMed ID: 17388789
[TBL] [Abstract][Full Text] [Related]
18. Relationship between the formation of promutagenic adducts and the activation of the K-ras protooncogene in lung tumors from A/J mice treated with nitrosamines.
Belinsky SA; Devereux TR; Maronpot RR; Stoner GD; Anderson MW
Cancer Res; 1989 Oct; 49(19):5305-11. PubMed ID: 2670201
[TBL] [Abstract][Full Text] [Related]
19. Deletion of cyclooxygenase-2 inhibits K-ras-induced lung carcinogenesis.
Pan Y; Jiang Y; Tan L; Ravoori MK; Gagea M; Kundra V; Fischer SM; Yang P
Oncotarget; 2015 Nov; 6(36):38816-26. PubMed ID: 26452035
[TBL] [Abstract][Full Text] [Related]
20. Role of ERK-MAPK signaling pathway in pentagastrin-regulated growth of large intestinal carcinoma.
Mao JD; Wu P; Huang JX; Wu J; Yang G
World J Gastroenterol; 2014 Sep; 20(35):12542-50. PubMed ID: 25253956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
